Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Osmotic device for administering certain drugs|
|Abstract:||An osmotic system is disclosed comprising a wall comprising in at least a part of a semipermeable material that surrounds a compartment. The compartment contains an osmotic composition comprising a beneficial drug selected from the group consisting of nifedipine, prazosin and doxazosin, and a second and different osmotic composition. A passageway in the wall connects the first composition with the exterior of the system.|
|Inventor(s):||Wong; Patrick S. L. (Hayward, CA), Barclay; Brian L. (Sunnyvale, CA), Deters; Joseph C. (Mt. View, CA), Theeuwes; Felix (Los Altos, CA)|
|Assignee:||Alza Corporation (Palo Alto, CA)|
Patent Claim Types:|
see list of patent claims
|Dosage form; Device; Composition; Delivery; Use;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|France||2545721||<disabled in preview>|
|Spain||532018||<disabled in preview>|
|Denmark||163910||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.